Beclometasone/formoterol

Beclometasone/formoterol, sold under the brand name Fostair and Luforbec, is an inhalable fixed-dose combination drug for the treatment of asthma and chronic obstructive pulmonary disease (COPD).^[3] It contains beclometasone dipropionate and formoterol fumarate dihydrate. It is inhaled.^[3]

Beclometasone/formoterol

Combination of
Beclometasone dipropionate	Glucocorticoid
Formoterol fumarate	Long-acting β2 agonist
Clinical data
Trade names	Fostair, Luforbec, Bibefco, Proxor, Vivaire [1]
AHFS/Drugs.com	International Drug Names
Routes of administration	Inhalation
ATC code	R03AL09 (WHO)
Legal status
Legal status	AU: S4 (Prescription only)[2] UK: POM (Prescription only)[3][4][5]

It was approved for medical use in the United Kingdom in 2007,^[3] and in Australia in February 2020.^[6][7] It is on the World Health Organization's List of Essential Medicines.^[8]